Medical versus medical and surgical treatment for brucella endocarditis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23102495.
- Also identified by DOI 10.1016/j.athoracsur.2012.07.006 and PMC identifier 3508082.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This review was undertaken to determine the role of surgery in the treatment of brucella endocarditis. All English and French articles reporting brucella endocarditis (1966 to 2011) in PubMed, Google, and Scopus were reviewed. In all, 308 cases were identified, and linear and logistic regression was performed. Surgery improved outcomes by decreasing mortality from 32.7% in the medical treatment only group to 6.7% in the combined surgical and medical treatment group (p<0.001). This association was still significant while controlling for other contributing factors. In the absence of a controlled trial, we recommend the utmost vigilance and consideration of surgical management in treating such patients.
Medical subject headings
- Anti-Bacterial Agents
- Brucella
- Brucellosis
- Cardiac Surgical Procedures
- Endocarditis, Bacterial